Management of breast cancer patients with

BRCA mutation BRCA testing breast cancer genetic counseling mutational analysis poly ADP ribose polymerase (PARP) inhibitor

Journal

Hospital practice (1995)
ISSN: 2154-8331
Titre abrégé: Hosp Pract (1995)
Pays: England
ID NLM: 101268948

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 23 9 2021
medline: 30 12 2021
entrez: 22 9 2021
Statut: ppublish

Résumé

This commentary explores and discusses the challenges oncologists face in diagnosing and managing breast cancer patients with Key opinion leaders shared their recommendations to achieve better patient outcomes and satisfaction based on evidence-based medicine and their clinical experience in Challenges associated with Genetic counseling, continuing education, infrastructure, testing, expertise, and financial support are needed to fulfill the unmet needs in the management of

Sections du résumé

BACKGROUND BACKGROUND
This commentary explores and discusses the challenges oncologists face in diagnosing and managing breast cancer patients with
METHODS METHODS
Key opinion leaders shared their recommendations to achieve better patient outcomes and satisfaction based on evidence-based medicine and their clinical experience in
RESULTS RESULTS
Challenges associated with
CONCLUSION CONCLUSIONS
Genetic counseling, continuing education, infrastructure, testing, expertise, and financial support are needed to fulfill the unmet needs in the management of

Identifiants

pubmed: 34547975
doi: 10.1080/21548331.2021.1974678
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-329

Auteurs

Nagi S El Saghir (NS)

Division of Hematology Oncology, American University of Beirut Medical Center, Beirut, Lebanon.

Hady Ghanem (H)

Division of Hematology Oncology, Lebanese American University Medical Center - Rizk Hospital, Beirut, Lebanon.

Fadi El Karak (F)

Department of Oncology-Hematology, School of Medicine, Saint Joseph University, Beirut, Lebanon.

Fadi Farhat (F)

Division of Hematology Oncology, Hammoud Hospital University Medical Center, Saida, Lebanon.

Marwan Ghosn (M)

Hematology Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

Joseph Makdessi (J)

Hematology and Oncology Department, Saint George Hospital University Medical Center, Beirut, Lebanon.

Khouloud Chouaib (K)

Oncology Department, Medical Affairs, Pfizer Africa - Middle East Region, Lebanon.

Jamil Debs (J)

Oncology Department, Medical Affairs, Pfizer Africa - Middle East Region, Lebanon.

Adel B Tabchy (AB)

Department of Hematology/Oncology, Saint-Joseph University - School of Medicine, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH